Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice. - Wikidata - thesis-toulmin - TriplyDB

Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice.

Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice.

http://www.wikidata.org/entity/Q36543639

about

Aldo-keto Reductase 1B15 (AKR1B15): a mitochondrial human aldo-keto reductase with activity toward steroids and 3-keto-acyl-CoA conjugates 4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product Implications of autophagy for vascular smooth muscle cell function and plasticity Insulin resistance, hyperglycemia, and atherosclerosis A potential therapeutic role for aldose reductase inhibitors in the treatment of endotoxin-related inflammatory diseases Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes Inhibition of vascular smooth muscle cell proliferation by Gentiana lutea root extracts Exposure to acrolein by inhalation causes platelet activation Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.Atherogenesis and metabolic dysregulation in LDL receptor-knockout rats.PDGF-mediated autophagy regulates vascular smooth muscle cell phenotype and resistance to oxidative stress Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.Cardiomyocyte aldose reductase causes heart failure and impairs recovery from ischemia.Evaluation of the aldose reductase inhibitor fidarestat on ischemia-reperfusion injury in rat retina.Oral exposure to acrolein exacerbates atherosclerosis in apoE-null mice.Bioenergetic function in cardiovascular cells: the importance of the reserve capacity and its biological regulation Aldose reductase deficiency protects from autoimmune- and endotoxin-induced uveitis in mice.Oxidative and reductive metabolism of lipid-peroxidation derived carbonyls.Reductive metabolism increases the proinflammatory activity of aldehyde phospholipids Detoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implications RAGE Suppresses ABCG1-Mediated Macrophage Cholesterol Efflux in Diabetes.Human aldose reductase expression accelerates atherosclerosis in diabetic apolipoprotein E-/- mice Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.Lipid peroxidation product 4-hydroxy-trans-2-nonenal causes endothelial activation by inducing endoplasmic reticulum stress Vascular complications of diabetes: mechanisms of injury and protective factors Aldose reductase, oxidative stress and diabetic cardiovascular complications Role of aldose reductase in the metabolism and detoxification of carnosine-acrolein conjugates.Aldose reductase (-106) C/T gene polymorphism and possibility of macrovascular complications in Egyptian type 2 diabetic patients.Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice.2013 Russell Ross memorial lecture in vascular biology: cellular and molecular mechanisms of diabetes mellitus-accelerated atherosclerosis.Aldose reductase and cardiovascular diseases, creating human-like diabetic complications in an experimental model.Role of phospholipid oxidation products in atherosclerosis.Molecular biology of atherosclerosis.Aldose reductase (AKR1B) deficiency promotes phagocytosis in bone marrow derived mouse macrophages.Beyond reactive oxygen species: aldehydes as arbitrators of alarm and adaptation.Synthesis, quantification, characterization, and signaling properties of glutathionyl conjugates of enals.Biomarkers of Chronic Acrolein Inhalation Exposure in Mice: Implications for Tobacco Product-Induced Toxicity.

P2860

Q24313499-1850A19B-057C-4FDC-89D3-0BBED83056CE Q26782039-3E43ED5C-9BEB-4617-B2EB-D5549896B3E4 Q26863422-2EF97437-90CA-468F-B04E-61F6CFA9BED3 Q27011696-40A7C4F4-2532-4778-9533-130732184BC2 Q28382891-4BD70A7C-496E-480E-A6F7-24B1E9CA9E5C Q28389004-0ADFC685-E268-412E-BB9B-4DAB3856602E Q28395675-C5430C40-2EE6-4195-8429-14653851FA60 Q28486286-7211C112-7692-4305-A824-BEAE9724FB3F Q28749132-F27A7615-9724-4ACE-B67F-A8F6234CFDF1 Q30248995-D63A35F4-4334-4A6A-8E0B-957366E7573C Q30968588-B0023392-B934-4C30-8621-A7F0E9F00512 Q33696216-90185AD1-DEBD-4989-90F3-36A4AE903D11 Q34049082-06090F17-060A-4198-AB47-7FE7BADF6C1A Q34431401-872DB26F-761E-48F0-BFD3-90A0C5DBC528 Q34603008-298897C3-815E-4469-95E8-695457A79606 Q34756881-D4889928-0D4E-4412-BD6A-5404911DC0C4 Q34961101-7749BD5E-7C1A-4FF4-BE28-C4F826F833B7 Q35522227-E3ED6873-966B-43FC-B326-D8CEB4E8E9AA Q35554080-C19D13CF-DD36-4838-B586-345FC29D5230 Q35561973-8FB4C151-E0E3-40E1-8D81-421A57EFCA66 Q35565861-B768A32D-AE79-45D2-BF4B-B5B8A6A83756 Q35740332-61831EA5-B5CD-405D-9CA4-295EAA0C6416 Q35753067-CBAC69AB-BFA3-4D13-97DB-D2ADAA9E2D9D Q35830289-B81E30F2-6F14-4A8A-AAA6-9C179219B026 Q35879593-9D0E41A5-9EB9-4734-AB3A-D50CCA7D26CA Q36537262-8A4DE70B-2D7D-4C0F-A0A3-4F2AF88A7E43 Q36777049-44ADD554-F728-4473-B6A1-C7A102241E6F Q37201268-433B672C-5988-450C-9FD9-32F72A8D2B6D Q37292061-4EE96F3A-36A8-42BC-8648-540624F62149 Q37406150-BE16567A-E080-4AEA-9249-D77021C2DAF4 Q37666671-3BAC000B-1D11-4275-9A2E-AC1FB5ED66A4 Q37751655-64614F6F-C1E5-407E-8595-18C1C2A36243 Q38039282-8D2DC0A7-83C7-45E8-B396-36BEEE34C7E4 Q38125279-DF43098B-7D2A-4933-BA16-8B9B356DEAD6 Q39006771-82811A80-F3C8-4E46-A38B-D2CE5479B560 Q42575984-5941612B-FC60-4B0F-B641-4C2F280BDF31 Q42651690-A7C932EB-FAD4-41D0-89E1-77634B124691 Q51015141-FDF7D3EE-C65E-44A5-B28E-70D066B576FA

P2860

Aldose reductase protects against early atherosclerotic lesion formation in apolipoprotein E-null mice.

http://www.wikidata.org/entity/Q36543639

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Aldose reductase protects agai ...... in apolipoprotein E-null mice.

@ast

Aldose reductase protects agai ...... in apolipoprotein E-null mice.

@en

type

label

Aldose reductase protects agai ...... in apolipoprotein E-null mice.

@ast

Aldose reductase protects agai ...... in apolipoprotein E-null mice.

@en

prefLabel

Aldose reductase protects agai ...... in apolipoprotein E-null mice.

@ast

Aldose reductase protects agai ...... in apolipoprotein E-null mice.

@en

P1433

Q36543639-67917D88-1060-4264-8DB0-40A4C1D2C1E5

P1476

Q36543639-F20AE8EE-4304-4D76-97AB-2F3ADAFF204E

P2093

Q36543639-003B3E7F-E8F1-4C9A-AF1A-4C1F502BC718

Q36543639-09CD5AAF-FA0C-4019-98AE-C66D0C402BA0

Q36543639-118632C2-9E82-4E7F-9930-73546FDCCDA1

Q36543639-385B5224-EA42-4A0E-A03D-1F6C5BC1A71A

Q36543639-506F7117-625A-4E0A-8271-5F1AC6912218

Q36543639-7B38DEB8-FD58-4E31-9C7D-9731857DD6BC

Q36543639-951AE065-C56B-450E-90FB-1581AF0B60B0

Q36543639-ACDFDACE-11F8-4CA1-A516-0C2C8C7605AD

Q36543639-EF04EF6F-9033-40DA-ABB4-49B0AA1CF30E

Q36543639-F8F60ACC-265D-432C-B1BA-B8060D3EE48F

P2860

Q36543639-04B9AF9D-2D12-471A-97E9-BA8DDEA68AC0

Q36543639-08C4A1BC-C838-4B08-AA94-C83993B659D1

Q36543639-0CC7C424-FEA3-43BE-BEDE-1A084686D168

Q36543639-115EE04B-3869-4E1E-9451-DA24DFE9D455

Q36543639-2D5CE0AE-021A-4ACE-A298-C47B7FD62ABA

Q36543639-35CA4E00-6A24-4C6D-B2DB-285451EB9619

Q36543639-37675753-19D3-4922-A6B2-87B41571368D

Q36543639-3A992C42-B097-4E56-8438-89E7AD9B016C

Q36543639-43C3C3F4-74C9-4EC0-BDED-F2B20D321485

Q36543639-45C37014-564B-427E-B077-1F3185BE324C

P304

Q36543639-89BDFAF1-9578-4882-A9D1-5C8BE3631598

P31

Q36543639-AFB36B72-46D9-438D-A69C-6079AF4AAAF5

P356

Q36543639-D3EDF2D3-A15C-4545-9A1C-01DB5EF6804B

P433

Q36543639-00973BD2-AC77-44D3-976E-886D0CCD63C3

P478

Q36543639-CD92AE99-8B81-4717-B5CC-12D760686CD1

P577

Q36543639-45821D14-3B37-45FA-BD97-0086A28BAF2E

P698

Q36543639-D4E18321-A5A6-468B-AD3D-DCE0F230DD10

P921

Q36543639-F200FCCA-5C81-4FC3-A897-2CA0D10B4996

P932

Q36543639-2476F694-C505-4F91-96AB-7ED27E86F44F

P356

CIRCRESAHA.109.200568

P1433

Circulation Research

P1476

Aldose reductase protects agai ...... in apolipoprotein E-null mice.

@en

P2093

Aruni Bhatnagar

http://www.w3.org/2001/XMLSchema#string

Buddhadeb Dawn

http://www.w3.org/2001/XMLSchema#string

Elena Vladykovskaya

http://www.w3.org/2001/XMLSchema#string

Greg Hunt

http://www.w3.org/2001/XMLSchema#string

J Mark Petrash

http://www.w3.org/2001/XMLSchema#string

Karin Kaiserova

http://www.w3.org/2001/XMLSchema#string

Matthew Spite

http://www.w3.org/2001/XMLSchema#string

Oleg A Barski

http://www.w3.org/2001/XMLSchema#string

Sanjay Srivastava

http://www.w3.org/2001/XMLSchema#string

Stephen S Chung

http://www.w3.org/2001/XMLSchema#string

P2860

Human aldose reductase expression accelerates diabetic atherosclerosis in transgenic mice

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease

Genetic restoration of aldose reductase to the collecting tubules restores maturation of the urine concentrating mechanism

Mitogenic responses of vascular smooth muscle cells to lipid peroxidation-derived aldehyde 4-hydroxy-trans-2-nonenal (HNE): role of aldose reductase-catalyzed reduction of the HNE-glutathione conjugates in regulating cell growth

Redox activation of aldose reductase in the ischemic heart

Role of oxidative modifications in atherosclerosis

Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis.

Aldose reductase-deficient mice develop nephrogenic diabetes insipidus.

Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options.

P304

793-802

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/CIRCRESAHA.109.200568

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19729598

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3548455

http://www.w3.org/2001/XMLSchema#string